Scipio bioscience
Single-cell profiling for every benchtop
Scipio bioscience, a Paris-based biotechnology company,
provides a novel sample preparation solution
for single-cell studies, in the form of benchtop kits,
for use in sequencing applications
in clinical and basic research,
in particular transcriptomics.
News
13 November 2017
Scipio bioscience announces its seed fund raising
A total of €1.2m has been obtained from two European seed funds: Paris, France-based Seventure Partners' Quadrivium I seed fund and Bonn, Germany-based High-Tech Gründerfonds. Read the full press release here.
The team
Science enthusiasts, driven by a common vision:
develop, deliver... and enjoy it!
Prof Stuart Edelstein
President - Chief Scientific Officer
Stuart is a world-renowned biophysicist. A foreign associate of the French Academy of Science, his academic curriculum includes professorships at Cornell University (NY, USA), University of Geneva (Switzerland), ENS (Paris, France) and the Collège de France. Stuart also has start-up experience as co-founder
of a publicly listed biotech company.
Pierre Walrafen, PhD
Chief Executive Officer
An Ecole Polytechnique alumnus and qualified European Patent Attorney, Pierre's experience in biotech covers all stages of product development and includes, in addition to 10+ years of R&D, positions as alliance manager for a strategic industrial partnership in DNA-based diagnostics and as consultant for biotechnology clients in an IP firm.
Alba Cico, PhD
R&D Project leader
Alba completed her PhD at the Commissariat à l'énergie atomique (CEA, Paris, France), where she studied molecular and epigenetic mechanisms of erythropoiesis. During her earlier studies, she completed internships at the St Judes Children's Research Hospital (Memphis, TN, USA) and at GSK.
Raya Poncin, PhD
R&D Project leader
Raya received her Ph.D. from the University of Toulouse III - Paul Sabatier, where she carried out research on biopolymers for tissue engineering and cell therapy applications. She graduated previously from the Paris Institute of Bioengineering and obtained a Master's degree in polymer science from University Paris-Est Créteil.
Maël Le Bohec, PhD
R&D Project leader
Maël completed his PhD in polymer chemistry in 2017 at the IMMM (Le Mans Institute of Molecules and Materials). His research focused on the design, synthesis and characterization of functionalized polymers, and in particular of PEGylated cationic polymers for transfection. His experience includes teaching general, organic, and polymer chemistry.
Jun Komatsu, PhD
Director of Innovation
Jun has more than 10 years of experience in biotech R&D and is an expert in structural and functional analysis of DNA molecules for genetic testing and biomedical research. With a background in general engineering and industrial chemistry, he received his PhD on the subject of micromanipulation of biological molecules in an electrostatics laboratory of the Toyohashi University of Technology (Japan).
Luc Walrafen
Chief Financial Officer
After graduating from ESSEC Business School, Luc worked, in France and Germany, for financial institutions and investment funds and then specialized in administering and advising start-ups at all stages of development in their structuration, business planning, fundraising and reporting.
Jörg Morf, PhD
R&D Advisor
A fellow of the Babraham Institute in Cambridge (UK), Jörg is pioneering research on the spatial organization of transcriptomes in health and disease. His expertise includes the design and implementation of novel genome-wide sequencing applications, such as high-throughput molecular barcoding, and computational analyses.
Allison Mallory, PhD
R&D Advisor
With a PhD in virology, Allison pursued post-doctoral work on plant microRNAs at the
MIT Whitehead Institute. She then joined INRA in Versailles, France to study small RNA-
directed gene regulation and RNA quality control. Allison is currently a Senior Scientist
at the Curie Institute in Paris investigating the roles and mechanisms of action of
vertebrate long noncoding RNAs.
Philippe Tramoy
Member of the Strategy Committee
Philippe, a partner at Seventure Partners, is in charge of life siences investments for the Quadrivium I fund. He started his career as a Project Manager and Director of Business Development Europe in the Rhodia group and later founded a market and business intelligence company, CBDMT – Market & Business Intelligence, which he managed for 10 years prior to joining Seventure.
Prof Stéphane Le Crom
Member of the Strategy Committee
Stéphane is the head of the Omics network of the Université Pierre et Marie Curie (UPMC, Paris, France) and of the genomics facility at the École normale supérieure (Paris). In addition to these positions, Stéphane teaches genomics at the UPMC, and heads a research team dedicated to data analysis from high-throughput genomics studies.
Frank Hensel, PhD
Member of the Strategy Committee
Frank is Senior Investment Manager at High-Tech Gründerfonds. He brings significant experience in biotechnology, as a scientist and founder of OncoMab GmbH, a spin-off of the University of Würzburg's Institute of Pathology. This expert in tumour-reactive antibodies focuses on the development of biologicals from the manufacturing phase to the clinical-trial stage.
Team up!
We love to work with individuals of diverse backgrounds, who share our vision of a happy workplace.

Contact us if you enjoy generously sharing your skills and expertise to produce something useful, want to join a team where all are expected to contribute equally to a collaborative and fruitful environment... and are ready to work hard on challenges aimed at achieving an entrepreneurial success, where effort will be justly rewarded.

We are not searching for CVs, but for persons... So let us know who you are in addition to what you have done. See our contact below!
Why keep an eye on us
Scipio Bioscience exploits a proprietary technology that allows the preparation of samples for single-cell profiling. Based on a novel combination of established biochemical and biophysical approaches, the Scipio technology achieves
single-cell barcoding in a test tube format.
Flexibility
The Scipio solution provides unmatched flexibility regarding cell type or applications. All are addressed in an easy-to-use test tube format
Scalability
Whether you are testing 10 samples per week or per year, you can use the Scipio solution in your own lab.
Price
No large investment is involved, since no specific device is needed, and consumables are a fraction of the cost of current solutions.
Our partners
We work hard and believe in what we do...
but there's not much we could do without them
ICM
The ICM - Brain & Spine Institute is a unique research cluster, innovative in its design and its organisation, gathering patients, physicians and researchers in a single location to allow for faster development of cures for lesions of the nervous system.
iPEPS - ICM
The incubator of the Institut du Cerveau et de la Moelle Epinière, iPEPS-ICM, offers extensive services and a prime location in the unmatched research environment of Paris' largest hospital, La Pitié-Salpêtrière.
Seventure Partners
The Quadrivium I seed fund, managed by Seventure Partners, invests in early-stage companies with links to one of twelve major universities and academic institutions, in digital technologies and life sciences.
High-Tech Gründerfonds
High-Tech Gründerfonds is Germany's most active seed stage investor, financing technology-driven companies in a wide range of fields to take their ideas through prototyping and to market launch.
Région Île-de-France
Scipio bioscience is supported by the Programme d'Investissements d'Avenir and the Région Île-de-France.
The Innov'up Leader PIA program is designed to support the development of global leaders on their market.
Contact us
We are located at the Institut du Cerveau et de la Moelle épinière
iPEPS - ICM
47 boulevard de l'hôpital
75013 Paris

Phone: +33 157 274 115

Email any of us at firstname.lastname@scipio.bio, if you are not a robot and replace firstname and lastname with our names.
Made on
Tilda